About this trial
This study aims to analyze the effects of physical activity in patients with chronic kidney disease undergoing dialysis or conservative treatment. Patients will be randomized into two groups: combined exercise (high-intensity aerobic resistance + strength training) and control group
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Signature of the informed consent
Patients with CKD stage 1 to 5 under conservative treatment
Patients undergoing chronic hemodialysis for at least 3 months
Age ≥ 18
Disqualifiers
Severe cardiovascular disease (NYHA class IV or hypertension class III)
TIA or myocardial ischemia within the last three months
Anatomical limitations
Health conditions detected during the stress test (CPET)
Trial design
Parallel
Treatments tested in this trial
Exercise
Other interventionAll participants will be involved in the exercise training three times per week for 24 weeks: endurance exercise training, resistant exercise training
control
Other interventionoutcome measures
Treatment groups
Trial outcomes
Primary outcomes
Gait speed (6MWT)
• Assess the effect of exercise on physical performance and quality of life on pa-tients with chronic kidney disease from stage 1 to end stage renal disease on maintenance haemodialysis or on conservative treatment
Physical performance (SPPB)
Cardiopulmonary capacity (CPET)
Lower limbs strength (1-RM)
Secondary outcomes
Nutritional status (24HR, FFQ)
Body composition (DEXA, BIVA)
Psychological and psychosocial conditions (BDI, MMSE)
Hemodynamic and vascular functions (SV, CO, HR, FBF, FMD, sPLM)
Other outcomes
effect of physical activity on mitochondrial activity
Investigate the effect of physical activity on mitochondrial activity by analyzing the expression of mitochondrial biomarkers, MOTS-c (mg)
Effect of physical activity on mitochondrial activity
Investigate the effect of physical activity on mitochondrial activity by analyzing the expression of mitochondrial biomarkers, humanin (mg)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.